Oxcarbazepine in women with epilepsy: Is safe oral contraception possible? First observations in patients, and an ongoing pharmacokinetic study in healthy women

被引：0
|
作者：
Stodieck, Stefan R. [1 ]
Schwenkhagen, A. [1 ,2 ]
Klatt, J. [3 ]
机构：
[1] Hamburg Epilepsy Ctr, Hamburg, Germany
[2] Gynaekoligicum, Hamburg, Germany
[3] Novartis Pharma GmbH, Nurnberg, Germany
来源：
EPILEPSIA | 2007年 / 48卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：341 / 341
页数：1
相关论文
共 8 条
  • [1] Pharmacokinetic study of different dosing regimens of levonorgestrel for emergency contraception in healthy women
    Johansson, E
    Brache, V
    Alvarez, F
    Faundes, A
    Cochon, L
    Ranta, S
    Lovern, M
    Kumar, N
    [J]. HUMAN REPRODUCTION, 2002, 17 (06) : 1472 - 1476
  • [2] Pharmacokinetic study of single and multiple oral administrations of 2 mg dienogest in healthy Korean women
    Shin, Donghoon
    Lee, SeungHwan
    Lim, Kyoung Soo
    Park, Joong Shin
    Shin, Sang-Goo
    Jang, In-Jin
    Yu, Kyung-Sang
    [J]. CONTRACEPTION, 2013, 87 (06) : 750 - 755
  • [3] Pharmacokinetic interaction study between riociguat and the combined oral contraceptives levonorgestrel and ethinylestradiol in healthy postmenopausal women
    Frey, Reiner
    Unger, Sigrun
    van der Mey, Dorina
    Becker, Corina
    Saleh, Soundos
    Wensing, Georg
    Mueck, Wolfgang
    [J]. PULMONARY CIRCULATION, 2016, 6 : S97 - S102
  • [4] FURTHER OBSERVATIONS ON CLINICAL EFFECTIVITY OF NEW LOW-DOSAGE ORAL PILLS FOR CONTRACEPTION IN INDIAN WOMEN - A 4-YEAR STUDY
    SHAH, PN
    [J]. INDIAN JOURNAL OF MEDICAL RESEARCH, 1969, 57 (04) : 642 - &
  • [5] Pharmacokinetic interaction of solifenacin with an oral contraceptive containing ethinyl estradiol and levonorgestrel in healthy women: A double-blind, placebo-controlled study
    Taekema-Roelvink, MEJ
    Swart, PJ
    Kuipers, ME
    Krauwinkel, WJJ
    Visser, N
    Smulders, RA
    [J]. CLINICAL THERAPEUTICS, 2005, 27 (09) : 1403 - 1410
  • [6] Risk of recurrent venous thromboembolism among young women after a first event while exposed to combined oral contraception versus not exposed to: A cohort study
    Le Moigne, Emmanuelle
    Delluc, Aurelien
    Tromeur, Cecile
    Nowak, Emmanuel
    Mottier, Dominique
    Lacut, Karine
    Le Gal, Gregoire
    [J]. THROMBOSIS RESEARCH, 2013, 132 (01) : 51 - 55
  • [7] Phase I study of the novel oral steroidal antiestrogenic agent TAS-108, ascending single dose, safety, tolerance, and pharmacokinetic parameters in healthy postmenopausal women.
    Kuritani, J
    Abdelhameed, M
    Boyeson, M
    Dixon, RM
    Pfefferkorn, C
    Yonezawa, J
    Shindo, T
    Minami, Y
    Buzdar, AU
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2001, 69 (03) : 290 - 290
  • [8] Safety and Pharmacokinetics of the Oral Prostaglandin F2α Receptor Antagonist Tocolytic OBE022: A First-in-Human Study in Healthy Women.
    Pohl, Oliver
    Lorch, Ulrike
    Marchand, Line
    Gotteland, Jean-Pierre
    [J]. REPRODUCTIVE SCIENCES, 2018, 25 : 265A - 266A
1